Clinical Trial Update: Sildenafil for the Treatment of Lymphatic Malformations [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sildenafil for treating lymphatic malformations; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Diseases
• Lymphatic Malformations

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Stanford University | Conditions: Lymphatic Malformations, Lymphatic Diseases | Phase 2 | Status: COMPLETED | Results posted: 2022-11-17